FARLEY CAPITAL L.P. - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 330 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2017. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.

Quarter-by-quarter ownership
FARLEY CAPITAL L.P. ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q4 2017$1,075,000
-72.4%
51,725
-81.0%
1.51%
-65.4%
Q3 2017$3,900,000
-17.2%
272,1480.0%4.36%
-18.4%
Q2 2017$4,708,000
+56.8%
272,1480.0%5.34%
+45.3%
Q1 2017$3,002,000
-24.0%
272,1480.0%3.68%
-29.6%
Q4 2016$3,952,000
-46.1%
272,148
-8.9%
5.22%
-46.2%
Q3 2016$7,332,000
+18.4%
298,648
-2.9%
9.70%
+0.5%
Q2 2016$6,192,000
-23.4%
307,4580.0%9.65%
-15.8%
Q1 2016$8,086,000
-64.2%
307,458
+38.3%
11.46%
-55.4%
Q4 2015$22,595,000
-34.1%
222,282
+15.7%
25.68%
-5.5%
Q3 2015$34,272,000
+9.4%
192,130
+36.2%
27.18%
+12.5%
Q2 2015$31,328,000
+11.8%
141,0200.0%24.16%
+9.3%
Q1 2015$28,009,000
-25.6%
141,020
-46.4%
22.10%
-17.1%
Q4 2014$37,626,000
-16.0%
262,920
-23.0%
26.64%
-11.5%
Q3 2014$44,807,000
+6.7%
341,518
+2.5%
30.12%
+11.2%
Q2 2014$42,008,000
+14.7%
333,081
+19.9%
27.09%
+19.9%
Q1 2014$36,624,000
+26.2%
277,812
+12.4%
22.59%
+24.9%
Q4 2013$29,012,000
+12.5%
247,1210.0%18.09%
+1.8%
Q3 2013$25,782,000
+21.3%
247,121
+0.1%
17.78%
+10.1%
Q2 2013$21,249,000246,85616.14%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q2 2017
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders